Casadó Vicent - Dept Biochem & Mol Biomed, Univ Barcelona

E. Moreno Guillén, P.A. De Oliveira, N. Casajuana-Martin,V. Casadó-Anguera, C. Ning-Sheng, G.A. Camacho-Hernandez, H. Zhu, A. Bonifazi, M.D. Hall, D. Weinshenker,A.H. Newman, D.E. Logothetis,V. Casado, L.D. Plant,L. Pardo,S. Ferré

Neuroscience Applied (2023): 102719

引用0浏览0引用

CB1R AS A POTENTIAL THERAPEUTIC TARGET IN CRBN DEFICIENCY-ASSOCIATED MENTAL RETARDATION

C. Costas Insua,A. Hermoso-Lopez,E. Moreno,A. Alvaro-Blazquez, C. Montero,D. Martin-Gutierrez, I. B. Maroto,R. Diez-Alarcia,L. Uriguen,V. Casado,I. Rodriguez-Crespo,M. Guzman

IBRO neuroscience reports（2023）

引用0浏览0引用

Selective Inhibition of Cannabinoid CB1 Receptor-Evoked Signalling by the Interacting Protein GAP43

Irene B. Maroto,Estefania Moreno,Carlos Costas-Insua,Javier Merino-Gracia,Rebeca Diez-Alarcia,Alicia Alvaro-Blazquez,Angeles Canales,Enric I. Canela,Vicent Casado,Leyre Uriguen,Ignacio Rodriguez-Crespo,Manuel Guzman

Neuropharmacology (2023)

引用0浏览0WOS引用

Significant Functional Differences Between Dopamine D4 Receptor Polymorphic Variants Upon Heteromerization with Α1a Adrenoreceptors

Patricia Homar-Ruano,Ning-Sheng Cai,Verònica Casadó-Anguera,Vicent Casadó,Sergi Ferré,Estefanía Moreno,Enric I. Canela

Molecular neurobiologyno. 11 (2023): 6566-6583

引用0浏览0WOS引用

What Are the Current Trends in G Protein-Coupled Receptor Targeted Drug Discovery

Vicent Casadó,Verònica Casadó-Anguera

Expert opinion on drug discoveryno. 8 (2023): 815-820

引用1浏览0引用

Heteromer-selective antagonists for the adenosine A1-dopamine D1 receptor heteromer. Potential drugs for spinal cord injury treatment

N. Llopart Jiménez,V. Casadó-Anguera, A. Alonso-Carrasco,E. Moreno,V. Casadó

Neuroscience Applied (2023): 103527

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn